About Us

Greeting from Chairperson

I would like to say a few words of greeting as the newly appointed Chairperson of the Japan Society of Gynecologic Oncology.
The field of so-called obstetrics and gynecology includes perinatal medicine that deals with pregnant women and newborns, reproductive medicine that deals with reproduction, women's medicine that deals with health management according to women's life stages focusing on menopause, and gynecologic oncology. The Japan Society of Gynecologic Oncology specializes in gynecologic oncology that deals with the early detection, prevention, diagnosis, and treatment of gynecologic tumors, including mainly cervical cancer, uterine body cancer, and ovarian cancer, which occur in the uterus, ovaries and other gynecologic organs. The Society is an academic group consisting of physicians specialized in the diagnosis and treatment of tumors, including gynecologists, pathologists, radiation oncologists, medical oncologists, and diagnostic imaging specialists. In addition, it aims to further improve women's life stages through educational as well as medical activities in collaboration with different fields of obstetrics and gynecology, and is conducting academic activities to deliver medical cares based on wider perspective.

The Society has its origin in the Japanese Society for Colposcopy, which was established in August 1975. In July 1998, its name was changed to Japan Society of Gynecologic Oncology, a specified non-profit corporation (NPO), through mergence with related academic societies and research groups, aiming at serving the public interest, and was certified in 2013 as a public interest incorporated association, the Japan Society of Gynecologic Oncology. In 2021, it was certified as a member society of the Japanese Association of Medical Sciences.

The ultimate goal of the activities of our society is to promote medical care for gynecologic tumors, to further improve treatment outcomes, and to realize a society where post-treatment patients can come back and play active roles. In order to achieve this goal, we have performed various activities including (1) creating and revising treatment guidelines for gynecologic tumors aiming at equal accessibility to treatments and its enlightenment, (2) holding academic lecture sessions, web seminars, and workshops for developing human resources and educating physicians, (3) research promotion for activating researches and developing human resources, (4) timely dissemination of medical information mirroring the advances in medical technologies and the changes in medical contexts for providing information and raising awareness for women, patients, and physicians, (5) operating gynecologic-oncologist system for the certification/notification of specialist physicians, (6) publication of journals in English for research presentations and academic promotion, and (7) cooperation with related/international academic societies for information gathering and promoting joint researches.

Owing to the efforts of successive chairpersons including Dr. Hidetaka Katabuchi, the former chairperson, the Society has made significant development leading to a sustainable foundation. Based on this foundation, we aim for further improvement and development to stay with the times.
　Although the end of COVID-19 pandemic is still unseen with remaining anxiety (as of summer 2022), values of things are expected to change in various aspects in "post-corona era." I believe we will be able to contribute to further improvement of the quality of women's life stages by strengthening the training environment for gynecologic oncologists in education, clinical practice, and researches so that young physicians leading gynecologic oncology in the future can fully demonstrate their capabilities.

　I would appreciate the support and cooperation of the members of the society as well as the public.

August 2022
Japan Society of Gynecologic Oncology (public interest incorporated association)
Chairperson, Mikio Mikami